Characteristics of gastrointestinal symptoms and function following endoscopic submucosal dissection and treatment of the gastrointestinal symptoms using rikkunshito

Experimental and Therapeutic Medicine

Volumn 6, Issue 5, 2013, Pages 1083-1088

  Uehara, Ryohei ^a   Isomoto, Hajime ^a   Minami, Hitomi ^a   Yamaguchi, Naoyuki ^a   Ohnita, Ken ^a   Ichikawa, Tatsuki ^a   Takeshima, Fuminao ^a   Shikuwa, Saburo ^a   Nakao, Kazuhiko ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

Abdominal pain; Endoscopic submucosal dissection; Gastric cancer; Gastric emptying; Rikkunshito

Indexed keywords

PLANT MEDICINAL PRODUCT; RABEPRAZOLE; RIKKUNSHITO; UNCLASSIFIED DRUG;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BODY MASS; BREATH ANALYSIS; CLINICAL ARTICLE; CONSTIPATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ENDOSCOPIC SUBMUCOSAL DISSECTION; ERUCTATION; FEMALE; FLATULENCE; GASTROINTESTINAL SYMPTOM; HUMAN; MALE; PARALLEL DESIGN; PROSPECTIVE STUDY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; STOMACH CANCER; STOMACH EMPTYING; VERNER MORRISON SYNDROME;

EID: 84884801814     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2013.1299     Document Type: Article

References (36)

1. Othman MO and Wallace MB: Endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) in 2011, a Western perspective. Clin Res Hepatol Gastroenterol 35: 288-294, 2011.
2. Fujishiro M: Perspective on the practical indications of endoscopic submucosal dissection of gastrointestinal neoplasms. World J Gastroenterol 14: 4289-4295, 2008.
3. Kim SH, Moon JS, Youn YH, Lee KM and Lee SJ: Management of the complications of endoscopic submucosal dissection. World J Gastroenterol 17: 3575-3579, 2011.
4. Oda I, Saito D, Tada M, et al: A multicenter retrospective study of endoscopic resection for early gastric cancer. Gastric Cancer 9: 262-270, 2006.
5. Isomoto H, Shikuwa S, Yamaguchi N, et al: Endoscopic submucosal dissection for early gastric cancer: a large-scale feasibility study. Gut 58: 331-336, 2009.
6. Abe N, Takeuchi H, Ohki A, et al: Long-term outcomes of combination of endoscopic submucosal dissection and laparoscopic lymph node dissection without gastrectomy for early gastric cancer patients who have a potential risk of lymph node metastasis. Gastrointest Endosc 74: 792-797, 2011.
7. Chung IK, Lee JH, Lee SH, et al: Therapeutic outcomes in 1000 cases of endoscopic submucosal dissection for early gastric neoplasms: Korean ESD Study Group multicenter study. Gastrointest Endosc 69: 1228-1235, 2009.
8. Daneshmend TK, Hawkey CJ, Langman MJ, Logan RF, Long RG and Walt RP: Omeprazole versus placebo for acute upper gastro-intestinal bleeding: randomised double blind controlled trial. BMJ 304: 143-147, 1992.
9. Lee SH, Lee CK, Chung IK, et al: Optimal duration of proton pump inhibitor in the treatment of endoscopic submucosal dissection-induced ulcers: a retrospective analysis and prospective validation study. Dig Dis Sci 57: 429-434, 2012.
10. Tominaga K, Iwakiri R, Fujimoto K, et al; GERD 4 Study Group: Rikkunshito improves symptoms in PPI-refractory GERD patients: a prospective, randomized, multicenter trial in Japan. J Gastroenterol 47: 284-292, 2012.
11. Tatsuta M and Iishi H: Effect of treatment with liu-jun-zi-tang (TJ-43) on gastric emptying and gastrointestinal symptoms in dyspeptic patients. Aliment Pharmacol Ther 7: 459-462, 1993.
12. Seike J, Sawada T, Kawakita N, et al: A new candidate supporting drug, rikkunshito, for the QOL in advanced esophageal cancer patients with chemotherapy using docetaxel/5-FU/CDDP. Int J Surg Oncol 2011: 715623, 2011.
13. Hayakawa T, Arakawa T, Kase Y, et al: Liu-Jun-Zi-Tang, a kampo medicine, promotes adaptive relaxation in isolated guinea pig stomachs. Drugs Exp Clin Res 25: 211-218, 1999.
14. Mochiki E, Yanai M, Ohno T and Kuwano H: The effect of traditional Japanese medicine (Kampo) on gastrointestinal function. Surg Today 40: 1105-1111, 2010.
15. Revicki DA, Wood M, Wiklund I and Crawley J: Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease. Qual Life Res 7: 7-83, 1988.
16. Sanaka M and Nakata K: Stable isotope breath tests for assessing gastric emptying: A comprehensive review. J Smooth Muscle Res 46: 267-280, 2010.
17. Japanese Gastric Cancer Association: Japanese classification of gastric carcinoma - 2nd English edition. Gastric Cancer 1: 10-24, 1998.
18. Japanese Gastric Cancer Association: Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 14: 101-112, 2011.
19. Parkman HP and Jones MP: Tests of gastric neuromuscular function. Gastroenterology 136: 1526-1543, 2009.
20. Kelly KA: Gastric emptying of liquids and solids: roles of proximal and distal stomach. Am J Physiol 239: G71-G76, 1980.
21. Camilleri M, Malagelada JR, Brown ML, Becker G and Zinsmeister AR: Relation between antral motility and gastric emptying of solids and liquids in humans. Am J Physiol 249: G580-G585, 1985.
22. Tieerdsma HC, Smout AJ and Akkermans LM: Voluntary suppression of defecation delays gastric emptying. Dig Dis Sci 38: 832-836, 1993.
23. Lee OY: Asian motility studies in irritable bowel syndrome. J Neurogastroenterol Motil 16: 120-130, 2010.
24. Hattori T: Rikkunshito and ghrelin. Int J Pept 2010: 283549, 2010.
25. Kusunoki H, Haruma K, Hata J, et al: Efficacy of Rikkunshito, a traditional Japanese medicine (Kampo), in treating functional dyspepsia. Intern Med 49: 2195-2202, 2010.
26. Takahashi T, Endo S, Nakajima K, Souma Y and Nishida T: Effect of rikkunshito, a Chinese herbal medicine, on stasis in patients after pylorus-preserving gastrectomy. World J Surg 33: 296-302, 2009.
27. Kido T, Nakai Y, Kase Y, et al: Effects of rikkunshi-to, a traditional Japanese medicine, on the delay of gastric emptying induced by N(G)-nitro-L-arginine. J Pharmacol Sci 98: 161-167, 2005.
28. Takeda H, Sadakane C, Hattori T, et al: Rikkunshito, an herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2 receptor antagonism. Gastroenterology 134: 2004-2013, 2008.
29. Matsumura T, Arai M, Yonemitsu Y, et al: The traditional Japanese medicine Rikkunshito increases the plasma level of ghrelin in humans and mice. J Gastroenterol 45: 300-307, 2010.
30. Arai M, Matsumura T, Tsuchiya N, et al: Rikkunshito improves the symptoms in patients with functional dyspepsia, accompanied by an increase in the level of plasma ghrelin. Hepatogastroenterology 59: 62-66, 2012.
31. Arakawa T, Higuchi K, Fujiwara Y, et al: Gastroprotection by Liu-Jun-Zi-Tang (TJ-43): possible mediation of nitric oxide but not prostaglandins or sulfhydryls. Drugs Exp Clin Res 25: 207-210, 1999.
32. Nakai Y, Kido T, Hashimoto K, et al: Effect of the rhizomes of Atractylodes lancea and its constituents on the delay of gastric emptying. J Ethnopharmacol 84: 51-55, 2003.
33. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H and Kangawa K: Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402: 656-660, 1999.
34. van der Lely AJ, Tschöp M, Heiman ML and Ghigo E: Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev 25: 426-457, 2004.
35. Konturek PC, Brzozowski T, Pajdo R, et al: Ghrelin - a new gastroprotective factor in gastric mucosa. J Physiol Pharmacol 55: 325-336, 2004.
36. Fujitsuka N, Asakawa A, Uezono Y, et al: Potentiation of ghrelin signaling attenuates cancer anorexia-cachexia and prolongs survival. Transl Psychiatry 26: e23, 2011.